Alveolar Bile and Light Chain Immunoglobulin Depositions as an Unusual Complication of Transjugular Liver Biopsy Resulting in Bilhemia in a Patient with Multiple Myeloma
Status PubMed-not-MEDLINE Language English Country Switzerland Media electronic
Document type Case Reports, Journal Article
PubMed
40142680
PubMed Central
PMC11943367
DOI
10.3390/jcm14061871
PII: jcm14061871
Knihovny.cz E-resources
- Keywords
- alveolar bile deposition, alveolar light chain deposition, bilhemia, diffuse alveolar damage, multiple myeloma, transjugular liver biopsy,
- Publication type
- Journal Article MeSH
- Case Reports MeSH
Background: A 69-year-old man with multiple myeloma and left-sided heart failure presented to the hospital with a two-month fever. Method: A transjugular liver biopsy was performed due to the rapid progression of liver failure. The procedure was complicated by an intraperitoneal hemorrhage. The bleeding was managed expectantly. Result: Significantly elevated serum bilirubin levels occurred on the 13th day after liver biopsy. Increasing serum bilirubin levels were observed until the patient's death due to a biliovenous fistula at the liver biopsy site. Simultaneously, his slightly elevated liver enzymes returned to normal. The patient died 23 days after liver biopsy due to acute respiratory distress syndrome. Fistulous communication between the biliary tree and the hepatic venous system with subsequent bile leakage into the venous system (bilhemia) can lead to bile deposition in the lungs. Bile deposition in the lungs may potentiate and accelerate the development of diffuse alveolar damage with hyaline membranes. Conclusions: Lambda and kappa light chain deposition in the pulmonary alveoli in patients with multiple myeloma can mimic typical hyaline membranes.
1st Department of Surgery Louis Pasteur University Hospital Rastislavova 43 040 01 Košice Slovakia
Department of Pathology Louis Pasteur University Hospital Rastislavova 43 040 01 Košice Slovakia
Medicolegal Department of Health Care Surveillance Authority Ipeľská 1 043 74 Košice Slovakia
See more in PubMed
Behrens G., Ferral H. Transjugular liver biopsy. Semin. Interv. Radiol. 2012;29:111–117. doi: 10.1055/s-0032-1312572. PubMed DOI PMC
Funaki B. Hemorrhage after transjugular liver biopsy requiring embolization. Semin. Interv. Radiol. 2009;26:358–360. doi: 10.1055/s-0029-1242207. PubMed DOI PMC
Kalambokis G., Manousou P., Vibhakorn S., Marelli L., Cholongitas E., Senzolo M., Patch D., Burroughs A. Transjugular liver biopsy-indications, adequacy, quality of specimens, and complications-a systematic review. J. Hepatol. 2007;47:284–294. doi: 10.1016/j.jhep.2007.05.001. PubMed DOI
Beckmann M.G., Bahr M.J., Hadem J., Bredt M., Wedemeyer H., Schneider A.S., Kubicka S., Manns M.P., Strassburg C.P., Wedemeyer J. Clinical relevance of transjugular liver biopsy in comparison with percutaneous and laparoscopic liver biopsy. Gastroenterol. Res. Pract. 2009;2009:947014. doi: 10.1155/2009/947014. PubMed DOI PMC
Roskovicova V., Katuchova J., Madarova N., Lenart M., Kicka M., Gajdzik T., Knazovicky M., Veseliny E., Radonak J. Risk factors for post-ERCP complications. Bratisl. Lek. Listy. 2024;125:544–550. doi: 10.4149/BLL_2024_85. PubMed DOI
Navuluri R., Ahmed O. Complications of transjugular biopsies. Semin. Interv. Radiol. 2015;32:42–48. doi: 10.1055/s-0034-1396963. PubMed DOI PMC
García-Compean D., Cortés C. Transjugular liver biopsy. An update. Ann. Hepatol. 2004;3:100–103. doi: 10.1016/S1665-2681(19)32101-5. PubMed DOI
Sue M.J., Lee E.W., Saab S., McWilliams J.P., Durazo F., El-Kabany M., Kaldas F., Busuttil R.W., Kee S.T. Transjugular liver biopsy: Safe even in patients with severe coagulopathies and multiple biopsies. Clin. Transl. Gastroenterol. 2019;10:e00063. doi: 10.14309/ctg.0000000000000063. PubMed DOI PMC
Gurakuqi G.C., Stadlbauer V., Portugaller H.R., Högenauer C., Trauner M., Stauber R.E. Fatal hemobilia resulting from an iatrogenic arteriobiliary fistula as a rare complication of transjugular liver biopsy. Eur. J. Gastroenterol. Hepatol. 2008;20:83–86. doi: 10.1097/MEG.0b013e3282748f32. PubMed DOI
Dohan A., Guerrache Y., Dautry R., Boudiaf M., Ledref O., Sirol M., Soyer P. Major complications due to transjugular liver biopsy: Incidence, management and outcome. Diagn. Interv. Imaging. 2015;96:571–577. doi: 10.1016/j.diii.2015.02.006. PubMed DOI
Fnon N.F., Seleim H.M., Abdel-Wahab M.S., Sobh Z.K. Bile pulmonary embolism-related sudden death following an abdominal firearm injury: An autopsy case report and review of literature. Forensic Sci. Med. Pathol. 2021;17:493–497. doi: 10.1007/s12024-021-00394-w. PubMed DOI
Sandblom P., Jakobsson B., Lindgren H., Lunderquist A. Fatal bilhemia. Surgery. 2000;127:354–357. doi: 10.1067/msy.2000.103488. PubMed DOI
Brown C.Y., Walsh G.C. Fatal bile embolism following liver biopsy. Ann. Intern. Med. 1952;36:1529–1533. doi: 10.7326/0003-4819-36-6-1529. PubMed DOI
Kihira T., Konishi T., Shiraishi T., Yatani R., Nakano T. Fatal bile pulmonary embolism following percutaneous transhepatic cholangiodrainage: Case report and literature review. Angiology. 1993;44:725–730. doi: 10.1177/000331979304400909. PubMed DOI
Brozinsky S., DeSoto-Lapaix F., Jimenez F.A., Ostrowitz A. Bile emboli: A complication of PTD. J. Clin. Gastroenterol. 1981;3:135–137. doi: 10.1097/00004836-198106000-00006. PubMed DOI
Çakır M.S., Guzelbey T., Kınacı E., Sevinc M.M., Kilickesmez O. Delayed bilhemia complicating percutaneous transhepatic biliary drainage: Successful treatment with primary coil embolization. Radiol. Case Rep. 2018;14:269–272. doi: 10.1016/j.radcr.2018.11.013. PubMed DOI PMC
Balogh K. Pulmonary bile emboli. Sequelae of iatrogenic trauma. Arch. Pathol. Lab. Med. 1984;108:814–816. PubMed
Siddiqui J., Jaffe P.E., Aziz K., Forouhar F., Sheppard R., Covault J., Bonkovsky H.L. Fatal air and bile embolism after percutaneous liver biopsy and ERCP. Gastrointest. Endosc. 2005;61:153–157. doi: 10.1016/S0016-5107(04)02448-4. PubMed DOI
Schmidt-Mutter C., Breining T., Gangi A., Canela E., Jourdan I., Mutter D., Dupeyron J.P. Fatal bile pulmonary embolism after radiofrequency treatment of a hepatocellular carcinoma. Surg. Endosc. 2003;17:2028–2031. PubMed
Jusufi M.S., Makridis G., Feyerabend B., Oldhafer K.J. First report of a late lethal pulmonary biliary embolism following hepatic microwave ablation. Visc. Med. 2021;37:550–554. doi: 10.1159/000511932. PubMed DOI PMC
Turk E., Temir Z.G., Karkiner A., Memis A., Topalak O., Evciler H., Ucan B., Karaca I. Bilhemia, an unusual complication after blunt liver trauma in a child: Case report and review of the literature. Eur. J. Pediatr. Surg. 2010;20:212–214. doi: 10.1055/s-0030-1249697. PubMed DOI
Malgoire J.Y., Lardière-Deguelte S., Piardi T., Amroun K., Renard Y., de Mestier L., Kianmanesh R. Bilhemia: A rare complication of hepatic blunt trauma, non-interventional Management and present aspect. J. Trauma Treat. 2015;4:1000259.
Knapik M., Okoń K., Ulatowska-Białas M. Fatal pulmonary bile embolism associated with acute pancreatitis—A case report and review of the literature. Pol. J. Pathol. 2024;75:54–57. doi: 10.5114/pjp.2024.135762. PubMed DOI
Zhang M., Valentino M.A. Bilhemia: A rare complication of transjugular intraheptic portosytemic shunt. ACG Case Rep. J. 2015;3:60–62. doi: 10.14309/crj.2015.101. PubMed DOI PMC
Breznik S., Slanič A., Ivanecz A., Lučev J. Bilhemia after percutaneous liver tumor core biopsy with the percutaneous embolization of bilio-venous fistula with coils and onyx. Cureus. 2024;16:e61414. doi: 10.7759/cureus.61414. PubMed DOI PMC
Asad S.F., Singh S., Ahmad A., Khan N.U., Hadi S.M. Prooxidant and antioxidant activities of bilirubin and its metabolic precursor biliverdin: A structure-activity study. Chem. Biol. Interact. 2001;137:59–74. doi: 10.1016/S0009-2797(01)00209-5. PubMed DOI
Zheng Z., Chang Z., Chen Y., Li J., Huang T., Huang Y., Fan Z., Gao J. Total bilirubin is associated with all-cause mortality in patients with acute respiratory distress syndrome: A retrospective study. Ann. Transl. Med. 2022;10:1160. doi: 10.21037/atm-22-1737. PubMed DOI PMC
Zhai R., Sheu C.C., Su L., Gong M.N., Tejera P., Chen F., Wang Z., Convery M.P., Thompson B.T., Christiani D.C. Serum bilirubin levels on ICU admission are associated with ARDS development and mortality in sepsis. Thorax. 2009;64:784–790. doi: 10.1136/thx.2009.113464. PubMed DOI PMC
Lee M., Jang M., Jo J., Yu B., Lee G., Lee J., Lee S., Jeon Y., Choi K. Hyperbilirubinemia as a risk factor for mortality and morbidity in trauma patients. J. Clin. Med. 2023;12:4203. doi: 10.3390/jcm12134203. PubMed DOI PMC
Herrero R., Sánchez G., Asensio I., López E., Ferruelo A., Vaquero J., Moreno L., de Lorenzo A., Bañares R., Lorente J.A. Liver-lung interactions in acute respiratory distress syndrome. Intensive Care Med. Exp. 2020;8:48. doi: 10.1186/s40635-020-00337-9. PubMed DOI PMC
Vella F.S., Simone B., Giannelli G., Pesolo M., Ingravallo G., Gentile A., Antonaci S. Case of multiple myeloma mimicking an infectious disease with fever, intrahepatic cholestasis, renal failure, and pulmonary insufficiency. Am. J. Hematol. 2003;72:38–42. doi: 10.1002/ajh.10257. PubMed DOI
Meijer W.G., Van Marwijk Kooy M., Laddé B.E. A patient with multiple myeloma and respiratory insufficiency due to accumulation of paraprotein in the alveolar space. Br. J. Haematol. 1994;87:663–665. doi: 10.1111/j.1365-2141.1994.tb08338.x. PubMed DOI
Xie Z., Ghosh C.C., Patel R., Iwaki S., Gaskins D., Nelson C., Jones N., Greipp P.R., Parikh S.M., Druey K.M. Vascular endothelial hyperpermeability induces the clinical symptoms of Clarkson disease (the systemic capillary leak syndrome) Blood. 2012;119:4321–4332. doi: 10.1182/blood-2011-08-375816. PubMed DOI PMC
Zhang W., Ewan P.W., Lachmann P.J. The paraproteins in systemic capillary leak syndrome. Clin. Exp. Immunol. 1993;93:424–429. doi: 10.1111/j.1365-2249.1993.tb08195.x. PubMed DOI PMC
Yu P., Zhang J., Tian W., Kang Y. Confirmed Cryoglobulinemia and Hyperviscosity Syndrome Secondary to Multiple Myeloma-IgA Kappa from Routine Blood Test: A Case Report. Clin. Lab. 2020;66:1145–1148. doi: 10.7754/Clin.Lab.2019.191127. PubMed DOI